Nimika is a nonsteroidal anti-inflammatory drug (NSAID) from the sulfonanilide group.
Release form and composition
- Dispersible tablets (10 pcs. In aluminum blister packs, 2 or 10 packs in a carton box);
- Suspension for oral administration (30 ml in dark bottles, 1 bottle in a cardboard bundle complete with a measuring cap).
Active ingredient - nimesulide:
- 1 tablet - 50 or 100 mg;
- 5 ml of suspension - 50 mg.
Tablet auxiliaries: purified talc, starch (including gelatinized), sodium starch glycolate, citric acid monohydrate, microcrystalline cellulose, aspartame, magnesium stearate, colloidal silicon dioxide, purified water, and also banana flavoring (50 mg tablets) or fruity (100 mg tablets).
Suspension auxiliaries: xanthan gum, glycerin, glycerin, methylparaben, sucrose, polysorbate-80, sorbitol, fruit essence, colloidal silica, citric acid monohydrate, propylparaben, water, dye.
Indications for use
- As a febrifuge - for fever due to diseases of the respiratory system of bacterial or viral etiology;
- As an analgesic - with pain in the postoperative period, with injuries and injuries of the musculoskeletal system and soft tissues.
- Acute phase of peptic ulcer;
- Gastrointestinal bleeding;
- Severe renal / liver dysfunction;
- Children's age up to 12 years;
- Lactation (or breastfeeding should be stopped);
- Intolerance of non-narcotic analgesics (history of the aspirin triad);
- Hypersensitivity to the drug.
Relative (due to the risk of complications, caution should be exercised):
- Kidney disease;
- Heart failure;
- Arterial hypertension;
- Blurred vision;
- Type II diabetes.
Dosing and Administration
Nimik should be taken orally, preferably after a meal (to reduce the risk of side effects). Immediately before taking the pill must be dissolved in a spoonful of water.
Dose and duration of use are determined individually depending on the evidence. The average dose is 100 mg 2 times a day.
In this dosage form, the drug is usually prescribed to adolescents over 12 years of age.
Suspension should be taken orally.
The average dose is 1.5 mg / kg, the multiplicity of reception - up to 3 times per day.
The maximum permissible daily dose is 5 mg / kg. In the event that the calculated dose exceeds the recommended dose for adults (for children weighing more than 40 kg), the patient should be prescribed 100 mg 2 times a day.
- Gastrointestinal tract: pain in the area of epigastria, vomiting, ulcerative lesions of the mucous membranes, nausea, various stool disorders, increased hepatic transaminases;
- Central nervous system: weakness, drowsiness, dizziness;
- Blood system: thrombocytopenia, leukopenia, agranulocytosis, lengthening of bleeding time, hematuria, anemia;
- Metabolism: fluid retention;
- Allergic reactions, including urticaria, anaphylactic shock.
In connection with the likelihood of dizziness and drowsiness during the treatment period, it is recommended to abandon driving.
Having a high degree of connection with plasma proteins, nimesulide can displace other drugs from similar bonds, which leads to an increase in their action and an increase in toxicity. In particular, with simultaneous use of Nimik, it can influence the action of the following drugs: diuretics, lithium preparations, digoxin, phenytoin, methotrexate, anticoagulants, cyclosporine, other non-narcotic analgesics, antihypertensives and oral antidiabetic drugs.
Terms and conditions of storage
Store at room temperature out of the reach of children.
Shelf life - 2 years.